BACTERIOLOGICAL STUDY OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Main Article Content

Dr. Selvi I.
Dr. Uma A.
Dr. Edwin D.

Keywords

Acute exacerbations, Chronic Obstructive Pulmonary Disease, bacterial etiology, Antibiotic sensitivity.

Abstract

Background and objectives


Acute exacerbations are significant and frequent events in the natural history of Chronic Obstructive Pulmonary Disease (COPD). Majority of these exacerbations are of infectious etiology, bacteria are almost responsible for around 30-50% of cases. The purpose of this study was to determine the bacteriology of acute exacerbations of COPD in hospitalized patients in our institution and their antibiotic susceptibility pattern to formulate cost effective antibiotic strategy and reducing the emergence of drug resistance.


Methods


A prospective observational study was conducted among clinically diagnosed cases of acute exacerbations of COPD admitted in Medicine and Chest and Tuberculosis ward in Trichy SRM Medical College Hospital and Research Centre, Trichy. Direct gram stain was done for all sputum samples. The suitable sputum samples were cultured. Identification of organism and antimicrobial susceptibility testing was done by standard microbiological techniques.


Results


Significant growth of bacteria was obtained from 40.7% of sputum samples. Males (91.4%) were more affected than females (8.5%). The most common isolate was Klebsiella pneumoniae (39%), followed by Pseudomonas aeruginosa (29.7%), Acinetobacter baumanii (10.63%), E. coli (8.51%) and Staphylococcus aureus (7.8%). Drug sensitivity revealed that Gram negative isolates were sensitive to Levofloxacin (80.7%) followed by Amikacin (77.6%), Aztreonam (74.6%), Gentamicin (70.7%), Imipenem (68.4%) and Piperacillin-Tazobactam (66.9%).


Conclusion


Acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) cases were common in males more than 50 years of age mainly due to smoking habits. Gram negative bacteria were more frequently isolated in our patients and appropriate antimicrobial therapy should be started early depending on the antimicrobial sensitivity results, in the wake of an increasing drug resistance.

Abstract 178 | PDF Downloads 83

References

1. Chakraborty A, Choudhury A, Debnath J, et al. Bacteriological profile and antibiotic sensitivity pattern in acute exacerbation of advanced cases of chronic obstructive pulmonary disease (COPD). J Evid Based Med Health.2016; 3(1), 20-23.
2. Global initiative for chronic obstructive lung disease, global strategy for the diagnosis, management and prevention of chronic obstructive lung disease, updated 2015.
3. Aleemullah M F, Krishnamurthy V, Harish M, Arshad Akeel. Bacteriological profile of patients with AECOPD- Hospital based study. Int J Curr Microbiol App Sci 2016;5(4):84-90.
4. Patel AK, Luhadia AS, Luhadia SK. Sputum bacteriology and antibiotic sensitivity pattern of patients having acute exacerbation of COPD in India– A preliminary study. J Pulm Respir Med 2015;5:238.
5. Chawla K, Mukhopadhay C, Majumdar M, Bairy I. Bacteriological profile and their antibiogram from cases of acute exacerbations of chronic obstructive pulmonary disease: A hospital based study. Journal of Clinical and Diagnostic Research 2: 612-616.
6. Sharan H. Aerobic bacteriological study of acute exacerbations of chronic obstructive pulmonary disease. J Clin Diagn Res 2015;8:DC10–DC12.
7. El Korashy R I M, El-Sherif R H. Gram negative organisms as a cause of acute exacerbation of COPD. Egyptian Journal of Chest Diseases and Tuberculosis 2014;63,345-349.
8. SS. Ewig, Soler N, Gonzalez J, RCelis, M. ElEbiary, A. Torres. Evaluation of antimicrobial treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations, Crit. Care Med. 28 (2000) 692–697.
9. Sethi Sanjay. Bacteria in Exacerbations of Chronic Obstructive Pulmonary Disease. Phenomenon or Epiphenomenon? Chest 2000;117:375S-385S.
10. Koneman, E.W., Allen, S.D., Janda, W.M., Schrekenberger, P.C. 2006. Color Atlas and Text book of Diagnostic Microbiology; 6 th edn. Philadelphia: J B Lippencott.
11. Clinical and Laboratory Standard Institute. Performance Standard for Antimicrobial Susceptibility Testing; Twenty fifth Information Supplement. M 100-S25;2016; Vol.35 No.3.44-84.
12. Madhavi S, Ramarao MV, Janardhan rao R. Bacterial Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Journal of Microbiology and Biotechnology Research 2012;2:440-44.
13. Saxena S, Ramnani V K, Nema S, Tripathi K, Dave L, Srivastava N. Bacteriological profile in Acute Exacerbations of Chronic Obstructive Lung Disease (AECOPD). Annuals of International Medical and Dental Research.2016;2:5.
14. Iyer Parmeswaran G, Murphy TF. Chronic Obstructive Pulmonary Disease: role of bacteria and updated guide to antibacterial selection in the older patient. Drugs Aging.2009; 26(12):985-995.
15. Siripataravanit, Sudarat, et al. “Bacteria associated with Acute Exacerbations of Chronic Obstructive PulmonaryDisease requiring mechanical ventilation and antimicrobial management in Respiratory Care Unit of CentralChest Institute of Thailand.” Journal of the Medical Association of Thailand 95. Suppl 8 (2012): S11-18.
16. Viswambhar V, Vishnu sharma M, Harsha D S, Sabir C, Sowjanya, Anupama N. Research Journal of Pharmaceutical, Biological and Chemical Sciences.2013;4(2):1549-1558.
17. Anand K. Patel, Atul S. Luhadia and Shanthi Kumar Luhadia. Sputum Bacteriology and Antibiotic Susceptibility Pattern of Patients having Acute Exacerbation of COPD in India. J PulmRespir Med.2009;5-238-42.
18. Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A. Multiple-drug-resistant bacteria in patients with severe acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence, Risk factors, and Outcome, Crit. Care Med.2006;34: 2959–2966.
19. Ferrer M, Ioanas M, Arancibia F, Marco M A, de la Bellacasa J P, Torres A. Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease, Crit. Care Med. 2005;33: 2003–2009.